Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 62332-776

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 62332-776). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cipro-dexa-ciprofloxacin-structure (Cipro Dexa Ciprofloxacin Structure)

Chemical structure diagram of ciprofloxacin hydrochloride monohydrate, showing the molecular framework including a fluorinated quinolone core and attached piperazine ring.*

FDA Label Image

Cipro-dexa-dexamethasone-structure (Cipro Dexa Dexamethasone Structure)

Chemical structure depicting the active ingredient in Ciprofloxacin and Dexamethasone suspension drops, showing a steroidal framework typical of dexamethasone with various functional groups including hydroxyl, ketone, and fluorine substitutions.*

FDA Label Image

Cipro-dexa-figure-a (Cipro Dexa Figure A)

An instructional illustration showing hands being washed under running water, emphasizing proper handwashing technique with soapy lather. This image is typically used to demonstrate hand hygiene steps.*

FDA Label Image

Cipro-dexa-figure-b (Cipro Dexa Figure B)

An instructional diagram showing a person holding an otic suspension bottle with two hands. One hand stabilizes the bottle, while the other hand appears to be preparing to shake or apply the ear drops, indicating proper handling technique for Ciprofloxacin and Dexamethasone suspension/drops.*

FDA Label Image

Cipro-dexa-figure-c (Cipro Dexa Figure C)

Illustration showing a person lying on their side with the head tilted to expose the ear, demonstrating the proper position for administering ear drops.*

FDA Label Image

Cipro-dexa-figure-d (Cipro Dexa Figure D)

An instructional line drawing illustrating proper administration of ear drops. The illustration shows a hand holding a dropper bottle positioned above an ear, with a drop of liquid being applied into the ear canal, demonstrating auricular (otic) use for a suspension or drops medication.*

FDA Label Image

Cipro-dexa-figure-e (Cipro Dexa Figure E)

An instructional diagram showing how to administer ear drops. It depicts sequential hand positioning on the ear, focusing on the tragus, with a final step indicating to press or massage the area five times (5X) to help distribute the medication.*

FDA Label Image

Cipro-dexa-figure-f (Cipro Dexa Figure F)

An instructional illustration showing the proper technique for administering otic suspension drops into the ear canal. The hand is positioned to pull the ear upward and backward to straighten the ear canal for easier application of the drops.*

FDA Label Image

Cipro-dexa-container-label (Cipro Dexa Container Label)

Label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a sterile otic suspension for ear use only by Alembic Pharmaceuticals Inc. The 7.5 mL suspension contains ciprofloxacin hydrochloride equivalent to 3 mg/mL ciprofloxacin base and 1 mg/mL dexamethasone, with 0.1 mg benzalkonium chloride as preservative. Storage instructions specify 20°C to 25°C, avoiding freezing and light exposure.*

FDA Label Image

Cipro-dexa-carton-label (Cipro Dexa Carton Label)

Packaging label for Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, a sterile otic suspension in 7.5 mL size by Alembic Pharmaceuticals Inc. The label includes dosage form as suspension/drops, storage instructions, active and inactive ingredient details, barcode, and directions for ear use only. The product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.